Simon F. Campbell - Concepedia

Author

Simon F. Campbell

Also Known As

Campbell, Simon, S F Campbell, S. CAMPBELL, S. F. CAMPBELL, S. F. Campbell, S.F. Campbell, SIMON CAMPBELL, SIMON F. CAMPBELL, Simon Campbell, Simon F. CAMPBELL

103

Publications

Citations

H-Index

Concepts

All Affiliations

Pfizer (United Kingdom)Medicines for Malaria Venture Swiss Tropical and Public Health Institute Monash University GlaxoSmithKline (Spain)

About

Simon F. Campbell is an author at Pfizer (United Kingdom) specializing in pharmacology, drug discovery, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	21	1.1K
2	Natural Sciences	16	21	654
3	Engineering	6	6	181
4	Arts	1	1	63
5	Public Health	1	1	60

Simon F. Campbell

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
A novel multiple-stage antimalarial agent that inhibits protein synthesis Beatriz Baragaña, Irene Hallyburton, Neil R. Norcross, Nature Antiparasitic AgentMedicineMalariaPharmacologyProtein Synthesis	2015	452
Molecular recognition Simon J. Hubbard, Simon F. Campbell, Janet M. Thornton Journal of Molecular Biology	1991	362
Long-acting dihydropyridine calcium antagonists. 1. 2-Alkoxymethyl derivatives incorporating basic substituents John Arrowsmith, Simon F. Campbell, Peter E. Cross, Journal of Medicinal Chemistry	1986	211
2,4-Diamino-6,7-dimethoxyquinoline derivatives as .alpha.1-adrenoceptor antagonists and antihypertensive agents Simon F. Campbell, J. David Hardstone, Michael Palmer Journal of Medicinal Chemistry Molecular PharmacologyMedicinal Chemistry2,4-Diamino-6,7-dimethoxyquinoline DerivativesDerivative (Chemistry)Pharmacological Study	1988	160
Calcium Channel Blocking Properties of Amlodipine in Vascular Smooth Muscle and Cardiac Muscle In Vitro: Evidence for Voltage Modulation of Vascular Dihydropyridine Receptors Roger A. Burges, Donald G. Gardiner, Michael Gwilt, Journal of Cardiovascular Pharmacology	1987	128
Comparison of location and binding for the positively charged 1,4-dihydropyridine calcium channel antagonist amlodipine with uncharged drugs of this class in cardiac membranes. Ronald P. Mason, Simon F. Campbell, Sui‐Dong Wang, Molecular Pharmacology	1989	122
2,4-Diamino-6,7-dimethoxyquinazolines. 1. 2-[4-(1,4-Benzodioxan-2-ylcarbonyl)piperazin-1-yl] derivatives as .alpha.1-adrenoceptor antagonists and antihypertensive agents Simon F. Campbell, Michael Davey, J. David Hardstone, Journal of Medicinal Chemistry	1987	118
The geometries of interacting arginine‐carboxyls in proteins Juswinder Singh, Janet M. Thornton, M. Snarey, FEBS Letters	1987	98
Discovery of a Quinoline-4-carboxamide Derivative with a Novel Mechanism of Action, Multistage Antimalarial Activity, and Potent in Vivo Efficacy Beatriz Baragaña, Neil R. Norcross, Caroline Wilson, Journal of Medicinal Chemistry	2016	89
UK-69, 578, a novel inhibitor of EC 3.4.24.11 which increases endogenous ANF levels and is natriuretic and diuretic John C. Danilewicz, Paul L. Barclay, I. T. Barnish, Biochemical and Biophysical Research Communications Molecular PharmacologyNovel InhibitorMedicinePhysiologyEc 3.4.24.11	1989	68

Page 1